Skip to Content

Facts and Figures in R&D

Roche spends alsmost 10 billion Swiss francs on research and development and employs over 18,000 people in R&D.

A unique R&D network model and strong alliances with companies, universities and research institutions worldwide give our scientists broadest access to innovation.

Group R&D Expenditures in millions of CHF
20092008% change
CHF		% change
LC		2009
% of sales		2008
% of sales
Group9,8748,845+ 12+ 1220.119.4
Divisional R&D Expenditures in millions of CHF
2009% change
CHF		% change
LC		% of sales
Pharmaceuticals8,896131322.8
Diagnostics978459.7

Roche has Research centers around the world with scientists passionate about discovering medicines to meet the unmet medical needs of patients.

More scientists and physicians around the world design and conduct preclinical and clinical trials to transform promising compounds into clinically differentiated medicines.

The Research and Development sites focus on specific disease areas that are exploring multiple therapeutic modalities and using numerous strategic technologies to conduct R&D from early discovery and translational medicine to preclinical and clinical development.  They are:

LocationFocus area
Basel, Switzerland (R&D)Metabolics and Central Nervous System
Kulmbach Germany (R)RNA-based Therapeutics
Madison (WI), USA (R)RNA-based Therapeutics
Nutley (NJ), USA (R&D)Oncology, Inflammation, Virology and Metabolics,
RNA-based Therapeutics
Penzberg, Germany (R)Protein Therapeutics and Stem Cells
Schlieren, Switzerland (R)Protein Therapeutics
Shanghai, China (R&D)Research and Clinical Development
South San Francisco (CA), USA (R&D)Oncology, Inflammation, Virology, Ophtalmology
Strasbourg, France (R)Early Clinical Development
Sydney, Australia (D)Clinical Development Operations
Toronto, Canada (R)Protein Therapeutics
Welwyn, United Kingdom (R&D)Pharmaceutical Development